13F filing recap · Q2 2021
What did Pzena Investment Management buy in Q2 2021?
Reported stock-position changes between this filing and the previous one.
Stock value
$25.70B
Positions
165
Estimated turnover
9.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
HBANHuntington Bancshares Incorporated$48.06Mreported value+3.37M sharesVTKLYVtech Holdings Limited$1.46Mreported value+139.7K sharesPRAHPra Health Sciences Inc$558.0Kreported value+3.4K sharesSSNCSS&C Technologies Holdings, Inc.$474.0Kreported value+6.6K sharesPEverpure, Inc.$449.0Kreported value+23.0K sharesQRVOQorvo, Inc.$444.0Kreported value+2.3K sharesUTHRUnited Therapeutics Corporation$412.0Kreported value+2.3K sharesJAZZJazz Pharmaceuticals Plc$275.0Kreported value+1.5K sharesNOKNokia Corp$86.0Kreported value+16.3K shares